Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZhenFund is a Beijing-based seed and early-stage venture capital firm (over US$1B AUM) founded in 2011 by New Oriental co‑founders Bob Xiaoping Xu and Victor Qiang Wang (in collaboration with Sequoia Capital China), investing across sectors including internet, AI, education, fintech, and healthcare/life sciences.[1][3][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZhenFund.